• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Gangwal Healthcare is powered by innovation, driving health, wellness & healing.

    Apogenix’s asunercept demonstrates efficacy in COVID-19 trial

    PHARMATIMES

    Apogenix Receives €20.7 M in Public Funding for Pivotal Study and Preparation

    YAHOO

    Phase II trial to treat COVID-19 initiated in Vienna as an academia-industry

    PHARMABIZ

    Phase II trial to treat COVID-19 initiated in Vienna as an academia-industry

    PHARMABIZ

    Apogenix Advances Clinical Development of CD95L Inhibitor Asunercept

    YAHOO

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.